Drug repurposing constitutes anywhere from 10% to 50% of the current R&D spending and is a determining factor in the life cycle management of pharmaceutical products. Repurposing drug candidates are known for their safety, cost savings, and commercial benefits. Download this white paper to learn more about:
The drug repurposing development pathway Low-risk and cost-effective strategies Case study examples on bringing molecules to market faster | 